3Drew BJ,Ackerman MJ,Funk M,et al.On behalf of the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology,the Council on Cardiovascular Nursing,and the American College of Cardiology Foundation.Prevention of torsade de pointes in hospital settings:a scientific statement from the American Heart Association and the American College of Cardiology Foundation.Circulation,2010,121:1047-1060.
4Woosley RL,Chen Y,Freiman JP,et al.Mechanism of the cardiotoxicactions of terfenadine.JAMA,1993,269:1532-1536.
5De Bruin ML,Langendijk PN,Koopmans RP,et al.In-hospital cardiac arrest is associated with usa of nonantiarrhythmic QTcprolonging drugs.Br J Clin Pharmacol,2007,63:216-223.
6Dessertenne F.La tachycardie ventriculaire á deux foyers opposes variables.Arch Mal Coeur Vaiss,1966,59:263-272.
8De Bruin ML,Pettersson M,Meyboom RH,et al.Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.Eur Heart J,2005,26:590-597.
9Roden DM.Taking the "idio" out of "idiosyncratic" predicting torsades de pointes.Pacing Cli Electrophysiol,1998,21:1029-1034.
10Noble D,Noble PJ.Late sodium current in the patho-phsiology cardiovascular disease:consequence of sodium-calcium overload.Heart,2006,92 (Supple Ⅳ):1-5.
